PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name ▲ | Ligand Feature | Target Source | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
Type 1-fimbriae
|
unnamed ligand
|
Oligosaccharides
|
Urine
|
Man(a1-3)Man(a1-6)Man
|
Binding
|
||
Toxin A
|
unnamed ligand
|
Oligosaccharides
|
Human colonic cells
|
GalNAc(b1-3)Gal(b1-4)GlcNAc
|
Binding
|
||
C-terminal domain of toxin A molecules
|
unnamed ligand
|
Oligosaccharides
|
Human colonic cells
|
GalNAc(b1-3)Gal(b1-4)GlcNAc
|
Binding
|
||
Adhesins
|
unnamed ligand
|
Oligosaccharides
|
Mucos membranes of the genitourinary tract/rectum/oropharynx/conjunctiva
|
Gal(b1-4)GlcNAc(b1-4)Gal(b1-4)Glc
|
Binding
|
||
18-kDa proteins
|
unnamed ligand
|
Oligosaccharides
|
Mucos membranes of the genitourinary tract/rectum/oropharynx/conjunctiva
|
Gal(b1-4)GlcNAc(b1-4)Gal(b1-4)Glc
|
Binding
|
||
Unknown
|
unnamed ligand
|
Polyglycosylceramides
|
Rat small intestine
|
GalNAc(b1-3)[Gal(a1-3)]nGal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
unnamed ligand
|
Polyglycosylceramides
|
Rat small intestine
|
GalNAc(b1-3)[Gal(a1-3)]nGal(a1-4)Gal(b1-4)Glc(b1-1)Cer *n=1-5
|
Not Binding
|
||
Shiga toxin
|
unnamed ligand
|
Sialoglycosphingolipids
|
NeuAc(a2-6)[NeuAc(a2-3)]Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Unknown
|
unnamed ligand
|
Sialoglycosphingolipids
|
Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
Unknown
|
unnamed ligand
|
Sialoglycosphingolipids
|
NeuAc(a2-6)[NeuAc(a2-3)]Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01